Published in Brain Res on March 20, 1999
Dopaminergic terminals in the rat cortex. Science (1973) 1.73
Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects. J Pharmacol Exp Ther (2000) 1.56
Neural substrates of opiate withdrawal. Trends Neurosci (1992) 1.52
[Trial of electro-pharmacologic anesthesia in major urologic surgery]. Bull Acad Natl Med (1972) 1.40
Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. J Pharmacol Exp Ther (1994) 1.35
Opponent process theory of motivation: neurobiological evidence from studies of opiate dependence. Neurosci Biobehav Rev (1989) 1.33
Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J Pharmacol Exp Ther (1992) 1.29
Some evidence for the existence of dopaminergic neurons in the rat cortex. Brain Res (1973) 1.26
Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat. Eur J Pharmacol (1994) 1.26
Automated sleep staging systems in rats. J Neurosci Methods (1999) 1.18
The effects of 6-hydroxydopamine lesions of the nucleus accumbens and the mesolimbic dopamine system on oral self-administration of ethanol in the rat. Brain Res (1993) 1.14
Relationship between the locomotor hyperactivity induced by A10 lesions and the destruction of the fronto-cortical dopaminergic innervation in the rat. Brain Res (1978) 1.13
Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine. Neuroscience (1995) 1.11
Chronic morphine exposure and spontaneous withdrawal are associated with modifications of dopamine receptor and neuropeptide gene expression in the rat striatum. Eur J Neurosci (1999) 1.10
Corticotropin-releasing factor induces a place aversion independent of its neuroendocrine role. Brain Res (1992) 1.08
D-amphetamine-induced behavioral sensitization: implication of a glutamatergic medial prefrontal cortex-ventral tegmental area innervation. Neuroscience (1999) 1.08
Central administration of a CRF antagonist blocks the development of stress-induced behavioral sensitization. Brain Res (1990) 0.98
Social deprivation enhances the vulnerability of male Wistar rats to stressor- and amphetamine-induced behavioral sensitization. Psychopharmacology (Berl) (1995) 0.98
Clonidine blocks acquisition but not expression of conditioned opiate withdrawal in rats. Neuropsychopharmacology (1998) 0.97
Radiofrequency lesion of the ventral mesencephalic tegmentum: neurological and behavioral considerations. Exp Neurol (1976) 0.94
Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal. J Pharmacol Exp Ther (1999) 0.93
Interactions between D-ala-met-enkephalin, A10 dopaminergic neurones, and spontaneous behaviour in the rat. Behav Brain Res (1980) 0.91
Behavioral sensitization to amphetamine is dependent on corticosteroid receptor activation. Brain Res (1989) 0.91
Locomotor activation induced by infusion of endorphins into the ventral tegmental area: evidence for opiate-dopamine interactions. Proc Natl Acad Sci U S A (1980) 0.91
Disappearance of hoarding behavior after 6-hydroxydopamine lesions of the mesolimbic dopamine neurons and its reinstatement with L-dopa. Behav Neurosci (1985) 0.91
D-amphetamine-induced behavioral sensitization: effect of lesioning dopaminergic terminals in the medial prefrontal cortex, the amygdala and the entorhinal cortex. Neuroscience (2002) 0.90
Aversive properties of opiate receptor blockade: evidence for exclusively central mediation in naive and morphine-dependent rats. Brain Res (1988) 0.90
Hyperactivity and hypoactivity produced by lesions to the mesolimbic dopamine system. Behav Brain Res (1981) 0.90
Central administration of corticotropin releasing factor induces long-term sensitization to D-amphetamine. Brain Res (1993) 0.89
Real-time sleep-wake scoring in the rat using a single EEG channel. Sleep (1994) 0.89
Increased spontaneous activity following substance P infusion into A10 dopaminergic area. Nature (1978) 0.89
Idazoxan and 8-OH-DPAT modify the behavioral effects induced by either NA, or 5-HT, or dual NA/5-HT reuptake inhibition in the rat forced swimming test. Neuropsychopharmacology (2001) 0.88
Small doses of apomorphine and chronic administration of d-amphetamine reduce locomotor hyperactivity produced by radiofrequency lesions of dopaminergic A10 neurons area. Biol Psychiatry (1977) 0.87
Opposite change of in vivo dopamine release in the rat nucleus accumbens and striatum that follows electrical stimulation of dorsal raphe nucleus: role of 5-HT3 receptors. J Neurosci (1998) 0.87
Anatomical relationships between the ventral mesencephalic tegmentum--a 10 region and the locus coeruleus as demonstrated by anterograde and retrograde tracing techniques. J Neural Transm (1979) 0.87
Evidence for selective involvement of dopamine D1 receptors of the ventral tegmental area in the behavioral sensitization induced by intra-ventral tegmental area injections of D-amphetamine. J Pharmacol Exp Ther (1996) 0.87
Repeated stress increases locomotor response to amphetamine. Psychopharmacology (Berl) (1984) 0.86
Biphasic effect on nociception and antiopiate activity of the neuropeptide FF (FLFQPQRFamide) in the rat. Peptides (1994) 0.86
Acute and chronic amphetamine treatments differently regulate neuropeptide messenger RNA levels and Fos immunoreactivity in rat striatal neurons. Neuroscience (1995) 0.86
Substance P, neurotensin and enkephalin injections into the ventral tegmental area: comparative study on dopamine turnover in several forebrain structures. Brain Res (1989) 0.85
Behavioral effects of a lesion in the ventral mesencephalic tegmentum: evidence for involvement of A10 dopaminergic neurons. Adv Biochem Psychopharmacol (1977) 0.85
Adult rat vigilance states discrimination by artificial neural networks using a single EEG channel. Physiol Behav (1996) 0.85
Substance dependence as a compulsive behavior. J Psychopharmacol (1998) 0.85
Reactivity and plasticity in the amygdala nuclei during opiate withdrawal conditioning: differential expression of c-fos and arc immediate early genes. Neuroscience (2008) 0.85
Effects of SCH 23390, raclopride, and haloperidol on morphine withdrawal-induced aggression in male mice. Pharmacol Biochem Behav (1999) 0.84
Critical role of the hypothalamic pituitary adrenal axis in amphetamine-induced sensitization of behavior. Life Sci (1990) 0.84
Effects of morphine and naloxone on behaviour in the hot plate test: an ethopharmacological study in the rat. Psychopharmacology (Berl) (1994) 0.83
Differential mechanisms in the acquisition and expression of heroin-induced place preference. Psychopharmacology (Berl) (1989) 0.83
Increased sensitivity to (+)amphetamine self-administered by rats following meso-cortico-limbic dopamine neurone destruction. Nature (1979) 0.83
The distribution of the projection from the parataenial nucleus of the thalamus to the nucleus accumbens in the rat: an autoradiographic study. Exp Brain Res (1984) 0.83
Continuous quantitative monitoring of spontaneous opiate withdrawal: locomotor activity and sleep disorders. Pharmacol Biochem Behav (1998) 0.82
Interaction between neuropeptide FF and opioids in the ventral tegmental area in the behavioral response to novelty. Neuroscience (2002) 0.82
Behavioral expression of opiate withdrawal is altered after prefrontocortical dopamine depletion in rats: monoaminergic correlates. Neuropsychopharmacology (2001) 0.82
Discovery of the mesocortical dopaminergic system: some pharmacological and functional characteristics. Adv Biochem Psychopharmacol (1977) 0.82
Ethopharmacological analysis of naloxone-precipitated morphine withdrawal syndrome in rats: a newly-developed "etho-score". Psychopharmacology (Berl) (1995) 0.82
Effect of injections of 6-OHDA into either nucleus accumbens septi or frontal cortex on spontaneous and drug-induced activity. Neuropharmacology (1983) 0.82
Role of imidazoline receptors in the anti-aversive properties of clonidine during opiate withdrawal in rats. Eur J Neurosci (2005) 0.81
A non-invasive gating device for continuous drug delivery that allows control over the timing and duration of spontaneous opiate withdrawal. J Neurosci Methods (2004) 0.81
Short and long-term changes in dopamine and serotonin receptor binding sites in amphetamine-sensitized rats: a quantitative autoradiographic study. Brain Res (1995) 0.81
Review of neural network applications in sleep research. J Neurosci Methods (1998) 0.81
The cytology of dopaminergic and nondopaminergic neurons in the substantia nigra and ventral tegmental area of the rat: a light- and electron-microscopic study. Neuroscience (1983) 0.81
Comparison between conventional and neural network classifiers for rat sleep-wake stage discrimination. Neuropsychobiology (1997) 0.81
Ventral tegmental area infusion of substance P, neurotensin and enkephalin: differential effects on feeding behavior. Neuroscience (1986) 0.81
Behavioural activation induced in the rat by substance P infusion into ventral tegmental area: implication of dopaminergic A10 neurones. Neurosci Lett (1979) 0.80
GABAergic mechanisms within the ventral tegmental area: involvement of dopaminergic (A 10) and non-dopaminergic neurones. Psychopharmacology (Berl) (1982) 0.79
Amphetamine-induced conditioned activity in rats: comparison with novelty-induced activity and role of the basolateral amygdala. Behav Neurosci (1995) 0.79
Chronic neuroleptic treatment and mesolimbic dopamine denervation induce behavioural supersensitivity to opiates. Psychopharmacology (Berl) (1985) 0.79
Amphetamine, apomorphine and investigatory behavior in the rat: analysis of the structure and pattern of responses. Psychopharmacology (Berl) (1986) 0.79
Mapping of c-fos gene expression in the brain during morphine dependence and precipitated withdrawal, and phenotypic identification of the striatal neurons involved. Eur J Neurosci (2000) 0.79
Transcutaneous cranial electrical stimulation (Limoge's currents) decreases early buprenorphine analgesic requirements after abdominal surgery. Anesth Analg (1996) 0.79
Neurotensin, substance P, neurokinin-alpha, and enkephalin: injection into ventral tegmental area in the rat produces differential effects on operant responding. Psychopharmacology (Berl) (1989) 0.79
Transcutaneous cranial electrical stimulation increases the potency of nitrous oxide in humans. Anesthesiology (1982) 0.79
Is the dopaminergic mesocorticolimbic system necessary for intracranial self-stimulation? Biochemical and behavioral studies from A10 cell bodies and terminals. Behav Neural Biol (1979) 0.79
Transcutaneous electrical stimulation with Limoge current potentiates morphine analgesia and attenuates opiate abstinence syndrome. Biol Psychiatry (1990) 0.78
Transcranial electrical stimulation with high frequency intermittent current (Limoge's) potentiates opiate-induced analgesia: blind studies. Pain (1990) 0.78
Disappearance of hoarding and disorganization of eating behavior after ventral mesencephalic tegmentum lesions in rats. J Comp Physiol Psychol (1978) 0.78
Behavioral analysis of the effect of neurotensin injected into the ventral mesencephalon on investigatory and spontaneous motor behavior in the rat. Psychopharmacology (Berl) (1985) 0.78
Chronic treatment with five different neuroleptics elicits behavioral supersensitivity to opiate infusion into the nucleus accumbens. Biol Psychiatry (1986) 0.78
Behavioral analysis of the effect of substance P injected into the ventral mesencephalon on investigatory and spontaneous motor behavior in the rat. Psychopharmacology (Berl) (1985) 0.78
Neuropeptide FLFQRFamide receptors within the ventral mesenchephalon and dopaminergic terminal areas: localization and functional antiopioid involvement. Neuroscience (1995) 0.77
Is cortical dopamine only the precursor of noradrenaline? Br J Pharmacol (1973) 0.77
Transcranial electrical stimulation with Limoge's currents decreases halothane requirements in rats. Evidence for the involvement of endogenous opioids. Anesthesiology (1992) 0.77
Naloxone-induced opiate withdrawal produces long-lasting and context-independent changes in aggressive and social behaviors of postdependent male mice. Behav Neurosci (2000) 0.77
Amphetamine-induced conditioned activity is insensitive to perturbations known to affect pavlovian conditioned responses in rats. Behav Neurosci (1998) 0.77
Effects of two alpha 2 agonists, rilmenidine and clonidine, on the morphine withdrawal syndrome and their potential addictive properties in rats. Am J Cardiol (1988) 0.77
Self-stimulation and catecholamines. 3. Effect of imposed or self-stimulation in the area ventralis tegmenti on catecholamine utilization in the rat brain. Brain Res (1973) 0.76
Sleep impairments in rats implanted with morphine pellets. Neuropsychobiology (1999) 0.76
Behavioral sensitization induced by psychostimulants or stress: search for a molecular basis and evidence for a CRF-dependent phenomenon. Ann N Y Acad Sci (1992) 0.76
d-Ala-met-enkephalin injection into the ventral tegmental area: effect on investigatory and spontaneous motor behaviour in the rat. Psychopharmacology (Berl) (1988) 0.75
Chronic dopamine antagonism facilitates opiate-induced feeding. J Psychiatry Neurosci (1995) 0.75
Changes in cortical and subcortical levels of monoamines and their metabolites following unilateral ventrolateral cortical lesions in the rat. Brain Res (1983) 0.75
Dose dependent behavioural stimulation after local infusion of substance P into the ventral tegmental area in the rat [proceedings]. Br J Pharmacol (1979) 0.75
[Choice of local anesthetic. Comparative study of 4 molecules]. Chir Dent Fr (1987) 0.75
Distribution of dopaminergic terminals in rat cerebral cortex: role of dopaminergic mesocortical system in ventral tegmental area syndrome. Adv Biochem Psychopharmacol (1977) 0.75
A novel long-lasting dopamine receptor blocker: haloperidol-bovine serum albumin conjugate. Eur J Pharmacol (1985) 0.75
Intra-accumbens implants of embryonic dopaminergic neurons reverse the behavioral supersensitivity to opiates evoked by lesion of the mesolimbic dopaminergic pathway. Brain Res (1990) 0.75
Central administration of arginine vasotocin: effects on exploratory behavior in the rat. Psychopharmacology (Berl) (1982) 0.75
[Psychology of dental implantation]. Inf Dent (1966) 0.75